Emine Ahu Koç
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Emine Ahu Koç has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Mehmet Armagan Osmanagaoglu
Faculty of Medicine, Department of Perinatology, Karadeniz Technical University, Trabzon, Turkey
3 shared publications - Turhan Aran
Karadeniz Technical University Faculty of Medicine, Teratology Information Service, Trabzon, Turkey
3 shared publications - Hidayet Şal
Karadeniz Technical University
2 shared publications - Miraç Özalp
Department of Perinatology, Prof. Dr. Cemil Taşçıoglu City Hospital, Istanbul, Turkey
2 shared publications - Sakine Merve Aydın
Samsun Üniversitesi
2 shared publications - Ömer Demir
Department of Obstetrics and Gynecology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
2 shared publications
Latest Publications
- 24 September 2026
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- p. 1-7
The relationship between maternal c-type natriuretic peptide levels and fetal growth restriction
- 24 September 2026
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- p. 1-7
The relationship between maternal c-type natriuretic peptide levels and fetal growth restriction
- Open Access
- 16 September 2026
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 53 (9)
Serum Periostin Levels as a Predictor of Gestational Diabetes Mellitus
Background: Gestational diabetes mellitus (GDM) is a common pregnancy complication associated with adverse maternal and neonatal outcomes. The identification of novel biomarkers for GDM remains an important clinical objective. The aim of this study was to investigate whether maternal serum periostin levels measured between 24 and 28 weeks of gestation could serve as a biomarker for the diagnosis of GDM and to evaluate their association with maternal and neonatal outcomes. Methods: This case-control study was conducted at Samsun Training and Research Hospital between January 2024 and February 2025. Serum periostin levels were measured by enzyme-linked immunosorbent assay (ELISA). Results: Serum periostin levels were significantly higher in the GDM group than in the control group (101.4 (53.6) vs. 34.6 (23.9) ng/mL, p < 0.001). Correlation analysis revealed that serum periostin levels were positively correlated with fasting glucose (r = 0.453, p < 0.001), 1-hour oral glucose tolerance test (OGTT) (r = 0.525, p < 0.001), 2-hour OGTT (r = 0.481, p < 0.001), maternal body mass index (BMI) (r = 0.750, p < 0.001), and fetal birth weight (r = 0.351, p < 0.001). Receiver operating characteristic (ROC) curve analysis demonstrated excellent diagnostic performance for serum periostin (area under the curve [AUC] = 0.932, 95% confidence interval [CI]: 0.899–0.966, p < 0.001). The multivariable model showed even higher diagnostic accuracy (AUC = 0.976, 95% CI: 0.957–0.994, p < 0.001). Conclusions: Maternal serum periostin levels are significantly associated with the presence of GDM and adverse perinatal outcomes. These findings suggest that periostin may represent a potentially useful biomarker associated with GDM; however, its role in screening or prediction requires further prospective validation.
- 16 September 2026
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 53 (9)
Open AccessSerum Periostin Levels as a Predictor of Gestational Diabetes Mellitus
Background: Gestational diabetes mellitus (GDM) is a common pregnancy complication associated with adverse maternal and neonatal outcomes. The identification of novel biomarkers for GDM remains an important clinical objective. The aim of this study was to investigate whether maternal serum periostin levels measured between 24 and 28 weeks of gestation could serve as a biomarker for the diagnosis of GDM and to evaluate their association with maternal and neonatal outcomes. Methods: This case-control study was conducted at Samsun Training and Research Hospital between January 2024 and February 2025. Serum periostin levels were measured by enzyme-linked immunosorbent assay (ELISA). Results: Serum periostin levels were significantly higher in the GDM group than in the control group (101.4 (53.6) vs. 34.6 (23.9) ng/mL, p < 0.001). Correlation analysis revealed that serum periostin levels were positively correlated with fasting glucose (r = 0.453, p < 0.001), 1-hour oral glucose tolerance test (OGTT) (r = 0.525, p < 0.001), 2-hour OGTT (r = 0.481, p < 0.001), maternal body mass index (BMI) (r = 0.750, p < 0.001), and fetal birth weight (r = 0.351, p < 0.001). Receiver operating characteristic (ROC) curve analysis demonstrated excellent diagnostic performance for serum periostin (area under the curve [AUC] = 0.932, 95% confidence interval [CI]: 0.899–0.966, p < 0.001). The multivariable model showed even higher diagnostic accuracy (AUC = 0.976, 95% CI: 0.957–0.994, p < 0.001). Conclusions: Maternal serum periostin levels are significantly associated with the presence of GDM and adverse perinatal outcomes. These findings suggest that periostin may represent a potentially useful biomarker associated with GDM; however, its role in screening or prediction requires further prospective validation.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 71 (11) , e20251005
Does fear of childbirth in nulliparous women affect fetal outcomes?
OBJECTIVE: In this study, an investigation was undertaken to determine whether the well-being of the fetus is affected in pregnant women who have a severe fear of childbirth.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 71 (11) , e20251005
Open AccessDoes fear of childbirth in nulliparous women affect fetal outcomes?
OBJECTIVE: In this study, an investigation was undertaken to determine whether the well-being of the fetus is affected in pregnant women who have a severe fear of childbirth.
- 22 April 2021
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 22 (2) , 149-154
Changing Trends over the Years in Pregnancy Termination due to Fetal Anomalies
- 22 April 2021
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 22 (2) , 149-154
Changing Trends over the Years in Pregnancy Termination due to Fetal Anomalies
- 1 September 2018
- Published by Elsevier in Reproductive Toxicology
- Vol. 80, 152-153
Pseudoephedrine use in the first trimester
- 1 September 2018
- Published by Elsevier in Reproductive Toxicology
- Vol. 80, 152-153
Pseudoephedrine use in the first trimester